Back to Journals » Research and Reports in Neonatology » Volume 4

Making a choice: initial fraction of inspired oxygen for resuscitation at birth of a premature infant less than 32 weeks gestational age

Authors Moore G, Navabi B

Received 23 November 2013

Accepted for publication 26 November 2013

Published 31 January 2014 Volume 2014:4 Pages 1—7


Checked for plagiarism Yes

Gregory P Moore,1–3 Behdad Navabi2

1Department of Pediatrics, Division of Neonatology, Children's Hospital of Eastern Ontario, 2Department of Obstetrics and Gynecology, Division of Newborn Care, The Ottawa Hospital General Campus, 3Department of Pediatrics, University of Ottawa, Ottawa, ON, Canada

As briefly noted by Abdel-Hady and Nasef in their 2012 publication in Research and Reports in Neonatology,1 the best initial fraction of inspired oxygen (FiO2) to use during resuscitation of preterm neonates <32 weeks gestational age (GA) has not been clearly elucidated. Most recent neonatal resuscitation guidelines leave the difficult choice of the actual FiO2 in the hands of individual physicians. We believe that this letter, through review and discussion of the recent published literature, will aid physicians in this choice and confirm that, as per the opinion of Abdel-Hady and Nasef, the best present evidence-based choice for the initial FiO2 for resuscitating preterm infants <32 weeks GA appears to be 30%. However, determination of the ideal initial resuscitation gas requires further research assessing both short-term and long-term outcomes.

View original paper by Abdel-Hady and Nasef.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives

Zomer HD, Vidane AS, Gonçalves NN, Ambrósio CE

Stem Cells and Cloning: Advances and Applications 2015, 8:125-134

Published Date: 28 September 2015

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Animal models of ischemic stroke and their application in clinical research

Fluri F, Schuhmann MK, Kleinschnitz C

Drug Design, Development and Therapy 2015, 9:3445-3454

Published Date: 2 July 2015

Animal models of polymicrobial pneumonia

Hraiech S, Papazian L, Rolain JM, Bregeon F

Drug Design, Development and Therapy 2015, 9:3279-3292

Published Date: 26 June 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010